We are live on
!
Find out more
Marshall Wace North America Portfolio holdings
AUM
$23.5B
Turnover
51.87%
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$23.5B
AUM Growth
-$574M
(-2.4%)
Cap. Flow
-$385M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
23.48%
Holding
1,876
New
481
Increased
362
Reduced
407
Closed
492
Avg Time Held Equity + Options
0.6
years
Top 10 Avg Time Held Equity + Options
1.3
years
Top 20 Avg Time Held Equity + Options
1.1
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$232M |
| 2 |
Cisco
CSCO
|
+$212M |
| 3 |
Pfizer
PFE
|
+$187M |
| 4 |
Lamb Weston
LW
|
+$172M |
| 5 |
Comcast
CMCSA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$286M |
| 2 |
Meta Platforms (Facebook)
META
|
+$165M |
| 3 |
Elevance Health
ELV
|
+$160M |
| 4 |
Salesforce
CRM
|
+$160M |
| 5 |
TJX Companies
TJX
|
+$147M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.34% |
| 2 | Healthcare | 20.96% |
| 3 | Communication Services | 13.02% |
| 4 | Consumer Discretionary | 11.83% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1251
Strategic Education
STRA
$1.83B
| $294K | ﹤0.01% |
+4,166
| New | +$310K |
2021 Q3
0 quarters
|
|
1252
LCI Industries
LCII
$2.04B
| $293K | ﹤0.01% |
+2,174
| New | +$300K |
2021 Q3
0 quarters
|
|
1253
Universal Health Realty Income Trust
UHT
$531M
| $292K | ﹤0.01% |
+5,284
| New | +$311K |
2021 Q3
0 quarters
|
|
1254
NovaBridge Biosciences American Depositary Shares
NBP
$149M
| $291K | ﹤0.01% |
4,012
-64
| -2% | -$4.63K |
2021 Q2
1 quarter
|
|
1255
Novo Nordisk
NVO
$173B
| $290K | ﹤0.01% |
+6,028
| New | +$291K |
2021 Q3
0 quarters
|
|
1256
PLDT
PHI
$4.26B
| $289K | ﹤0.01% |
8,892
-30,507
| -77% | -$827K |
2021 Q1
2 quarters
|
|
1257
Waters Corp
WAT
$43.6B
| $286K | ﹤0.01% |
+801
| New | +$314K |
2021 Q3
0 quarters
|
|
|
SURF
1258
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $286K | ﹤0.01% |
+37,784
| New | +$242K |
2021 Q3
0 quarters
|
|
1259
AMN Healthcare
AMN
$1.55B
| $284K | ﹤0.01% |
2,474
+308
| +14% | +$32.7K |
2020 Q4
3 quarters
|
|
1260
Sonoco
SON
$4.91B
| $284K | ﹤0.01% |
+4,769
| New | +$305K |
2021 Q3
0 quarters
|
|
1261
Artivion
AORT
$1.07B
| $283K | ﹤0.01% |
+12,705
| New | +$327K |
2021 Q3
0 quarters
|
|
1262
Dime Commercial Bancshares
DCOM
$1.71B
| $283K | ﹤0.01% |
+8,671
| New | +$281K |
2021 Q3
0 quarters
|
|
1263
Heron Therapeutics
HRTX
$71.5M
| $282K | ﹤0.01% |
+26,362
| New | +$321K |
2021 Q3
0 quarters
|
|
1264
Allegro MicroSystems
ALGM
$6.03B
| $281K | ﹤0.01% |
8,815
-72,111
| -89% | -$2.13M |
2020 Q4
3 quarters
|
|
|
CSLT
1265
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $278K | ﹤0.01% |
177,019
+118,921
| +205% | +$233K |
2021 Q2
1 quarter
|
|
1266
Bristow Group
VTOL
$1.12B
| $277K | ﹤0.01% |
+8,689
| New | +$254K |
2021 Q3
0 quarters
|
|
1267
Customers Bancorp
CUBI
$2.51B
| $276K | ﹤0.01% |
+6,407
| New | +$249K |
2021 Q3
0 quarters
|
|
|
MRTX
1268
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $276K | ﹤0.01% |
1,558
-9,037
| -85% | -$1.45M |
2020 Q3
4 quarters
|
|
1269
Sprouts Farmers Market
SFM
$6.21B
| $275K | ﹤0.01% |
+11,878
| New | +$289K |
2021 Q3
0 quarters
|
|
1270
WesBanco
WSBC
$3.55B
| $275K | ﹤0.01% |
+8,081
| New | +$268K |
2021 Q3
0 quarters
|
|
1271
DELISTED
Simulations Plus
SLP
| $274K | ﹤0.01% |
+6,932
| New | +$316K |
2021 Q3
0 quarters
|
|
1272
Organon & Co
OGN
$3.61B
| $272K | ﹤0.01% |
8,297
-1,534
| -16% | -$49.1K |
2021 Q2
1 quarter
|
|
1273
CALL
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
| $272K | ﹤0.01% |
125,400
| – | – |
2020 Q4
3 quarters
|
|
1274
Credicorp
BAP
$30.8B
| $269K | ﹤0.01% |
+2,429
| New | +$265K |
2021 Q3
0 quarters
|
|
|
THRN
1275
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $268K | ﹤0.01% |
+30,993
| New | +$253K |
2021 Q3
0 quarters
|
|
Similar funds
NAM
Marshall Wace North America's Q3 2021 Portfolio in Review
As of Q3 2021, Marshall Wace North America held 1,876 positions worth $23.5B, down 2.4% from $24.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Marshall Wace North America's Q3 2021 filing shows 481 new, 362 increased, 407 reduced and 492 closed positions. Its largest new stake was Cisco: 3,779,633 shares worth $206M. The largest sale was Danaher, an estimated $286M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace North America's largest Q3 2021 buy was Cisco: 3,779,633 shares worth $206M.
- Marshall Wace North America added most to Uber in Q3 2021, an estimated $232M increase.
- Marshall Wace North America's biggest Q3 2021 reduction was Danaher, cutting an estimated $286M.
- Marshall Wace North America fully exited CIMAREX ENERGY CO in Q3 2021, selling an estimated $81.7M.
- Marshall Wace North America's ten largest holdings make up 23% of its $23.5B portfolio in Q3 2021.
- Marshall Wace North America opened 481 new positions and closed 492 in Q3 2021.
- Marshall Wace North America's portfolio value fell 2.4% quarter-over-quarter to $23.5B.
Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.